Register or Login
All
  • All
  • Uniprot Id
  • Catalog #
  • Peptide Sequence
>   home   >   Products   >   Primary Antibodies   >   Cell Biology   >   Ceramide Kinase / CERK Antibody (N-Terminus)   

Ceramide Kinase / CERK Antibody (N-Terminus)

Rabbit Polyclonal Antibody

     
  • IHC - Ceramide Kinase / CERK Antibody (N-Terminus) ALS10651
    Anti-CERK antibody ALS10651 IHC of human brain, cortex.
  • SPECIFICATION
  • CITATIONS
  • PROTOCOLS
  • BACKGROUND
Product Information
Application
  • Applications Legend:
  • WB=Western Blot
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin-embedded Sections)
  • IHC-F=Immunohistochemistry (Frozen Sections)
  • IF=Immunofluorescence
  • FC=Flow Cytopmetry
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • E=ELISA
  • IP=Immunoprecipitation
  • DB=Dot Blot
  • CHIP=Chromatin Immunoprecipitation
  • FA=Fluorescence Assay
  • IEM=Immunoelectronmicroscopy
  • EIA=Enzyme Immunoassay
IHC-P
Primary Accession Q8TCT0
Reactivity Human
Host Rabbit
Clonality Polyclonal
Calculated MW 60kDa
Dilution IHC-P (20 µg/ml)
Additional Information
Other Names Ceramide kinase, hCERK, 2.7.1.138, Acylsphingosine kinase, Lipid kinase 4, LK4, CERK, KIAA1646
Target/Specificity Human CERK. BLAST analysis of the peptide immunogen showed no homology with other human proteins.
Reconstitution & Storage Long term: -70°C; Short term: +4°C
PrecautionsCeramide Kinase / CERK Antibody (N-Terminus) is for research use only and not for use in diagnostic or therapeutic procedures.
Protein Information
Name CERK
Synonyms KIAA1646
Function Catalyzes specifically the phosphorylation of ceramide to form ceramide 1-phosphate. Acts efficiently on natural and analog ceramides (C6, C8, C16 ceramides, and C8-dihydroceramide), to a lesser extent on C2-ceramide and C6-dihydroceramide, but not on other lipids, such as various sphingosines. Binds phosphoinositides.
Cellular Location Cytoplasm. Membrane; Peripheral membrane protein
Tissue Location High level expression in heart, brain, skeletal muscle, kidney and liver; moderate in peripheral blood leukocytes and thymus; very low in spleen, small intestine, placenta and lung EMBL; AB079066; BAC01154.1; -; mRNA EMBL; AJ457828; CAD29884.1; -; mRNA EMBL; CR456404; CAG30290.1; -; mRNA EMBL; AK291476; BAF84165.1; -; mRNA EMBL; AL096766; -; NOT_ANNOTATED_CDS; Genomic_DNA EMBL; AL118516; -; NOT_ANNOTATED_CDS; Genomic_DNA EMBL; CH471138; EAW73440.1; -; Genomic_DNA EMBL; CH471138; EAW73442.1; -; Genomic_DNA EMBL; BC067255; AAH67255.1; -; mRNA EMBL; BC126940; AAI26941.1; -; mRNA EMBL; AB051433; BAB33316.1; -; mRNA CCDS; CCDS14077.1; -. [Q8TCT0-1] RefSeq; NP_073603.2; NM_022766.5. [Q8TCT0-1] UniGene; Hs.200668; - ProteinModelPortal; Q8TCT0; - BioGrid; 122291; 48 IntAct; Q8TCT0; 47 STRING; 9606.ENSP00000216264; - BindingDB; Q8TCT0; - ChEMBL; CHEMBL1764936; - GuidetoPHARMACOLOGY; 2473; - SwissLipids; SLP:000001354; - iPTMnet; Q8TCT0; - PhosphoSitePlus; Q8TCT0; - BioMuta; CERK; - DMDM; 30172885; - EPD; Q8TCT0; - MaxQB; Q8TCT0; - PaxDb; Q8TCT0; - PeptideAtlas; Q8TCT0; - PRIDE; Q8TCT0; - ProteomicsDB; 74154; - DNASU; 64781; - Ensembl; ENST00000216264; ENSP00000216264; ENSG00000100422. [Q8TCT0-1] GeneID; 64781; - KEGG; hsa:64781; - UCSC; uc003bia.4; human. [Q8TCT0-1] CTD; 64781; - DisGeNET; 64781; - EuPathDB; HostDB:ENSG00000100422.13; - GeneCards; CERK; - HGNC; HGNC:19256; CERK HPA; HPA064699; - MIM; 610307; gene neXtProt; NX_Q8TCT0; - OpenTargets; ENSG00000100422; - PharmGKB; PA134958321; - eggNOG; KOG1115; Eukaryota eggNOG; COG1597; LUCA GeneTree; ENSGT00690000101761; - HOGENOM; HOG000111551; - HOVERGEN; HBG050903; - InParanoid; Q8TCT0; - KO; K04715; - OMA; NSSWNCD; - OrthoDB; EOG091G0FFW; - PhylomeDB; Q8TCT0; - TreeFam; TF314514; - BRENDA; 2.7.1.138; 2681 Reactome; R-HSA-1660662; Glycosphingolipid metabolism SABIO-RK; Q8TCT0; - ChiTaRS; CERK; human GeneWiki; CERK; - GenomeRNAi; 64781; - PRO; PR:Q8TCT0; - Proteomes; UP000005640; Chromosome 22 Bgee; ENSG00000100422; - CleanEx; HS_CERK; - ExpressionAtlas; Q8TCT0; baseline and differential Genevisible; Q8TCT0; HS GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB GO; GO:0005886; C:plasma membrane; TAS:Reactome GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW GO; GO:0001729; F:ceramide kinase activity; IDA:UniProtKB GO; GO:0102773; F:dihydroceramide kinase activity; IEA:UniProtKB-EC GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro GO; GO:0006672; P:ceramide metabolic process; IDA:UniProtKB GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome Gene3D; 3.40.50.10330; -; 1 InterPro; IPR017438; ATP-NAD_kinase_N InterPro; IPR001206; Diacylglycerol_kinase_cat_dom InterPro; IPR016064; NAD/diacylglycerol_kinase_sf Pfam; PF00781; DAGK_cat; 1 SMART; SM00046; DAGKc; 1 SUPFAM; SSF111331; SSF111331; 3 PROSITE; PS50146; DAGK; 1 1: Evidence at protein level; Alternative splicing; ATP-binding; Calcium; Complete proteome; Cytoplasm; Kinase; Magnesium; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome; Transferase CHAIN 1 537 Ceramide kinase /FTId=PRO_0000181354 DOMAIN 128 278 DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783} NP_BIND 138 140 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} NP_BIND 170 174 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} NP_BIND 239 241 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} NP_BIND 502 504 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} REGION 1 125 Required for binding to sulfatide and phosphoinositides REGION 195 198 Substrate binding. ACT_SITE 197 197 Proton donor/acceptor. BINDING 202 202 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} BINDING 304 304 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} BINDING 310 310 ATP. {ECO:0000255|PROSITE- ProRule:PRU00783} MOD_RES 340 340 Phosphoserine MOD_RES 408 408 Phosphoserine VAR_SEQ 1 198 Missing (in isoform 2) /FTId=VSP_056944 VARIANT 191 191 I -> V (in dbSNP:rs16995615) /FTId=VAR_053685 VARIANT 211 211 T -> M (in dbSNP:rs9306515) /FTId=VAR_053686 VARIANT 306 306 L -> F (in dbSNP:rs13057352) /FTId=VAR_053687 MUTAGEN 10 10 L->A: 99% decrease in catalytic activity but no effect on substrate affinity MUTAGEN 10 10 L->I: 71% decrease in catalytic activity but no effect on substrate affinity MUTAGEN 340 340 S->A: 15% decrease in catalytic activity and decreased stability SEQUENCE 537 AA; 59977 MW; 3DBFC0ED8D679F7F CRC64; MGATGAAEPL QSVLWVKQQR CAVSLEPARA LLRWWRSPGP GAGAPGADAC SVPVSEIIAV EETDVHGKHQ GSGKWQKMEK PYAFTVHCVK RARRHRWKWA QVTFWCPEEQ LCHLWLQTLR EMLEKLTSRP KHLLVFINPF GGKGQGKRIY ERKVAPLFTL ASITTDIIVT EHANQAKETL YEINIDKYDG IVCVGGDGMF SEVLHGLIGR TQRSAGVDQN HPRAVLVPSS LRIGIIPAGS TDCVCYSTVG TSDAETSALH IVVGDSLAMD VSSVHHNSTL LRYSVSLLGY GFYGDIIKDS EKKRWLGLAR YDFSGLKTFL SHHCYEGTVS FLPAQHTVGS PRDRKPCRAG CFVCRQSKQQ LEEEQKKALY GLEAAEDVEE WQVVCGKFLA INATNMSCAC RRSPRGLSPA AHLGDGSSDL ILIRKCSRFN FLRFLIRHTN QQDQFDFTFV EVYRVKKFQF TSKHMEDEDS DLKEGGKKRF GHICSSHPSC CCTVSNSSWN CDGEVLHSPA IEVRVHCQLV RLFARGIEEN PKPDSHS
Volume 50 µl
Research Areas
Citations (0)

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.

Submit your citation using an Abgent antibody to
info@abgent.com, and receive a free "I Love Antibodies" mug.

Background

Catalyzes specifically the phosphorylation of ceramide to form ceramide 1-phosphate. Acts efficiently on natural and analog ceramides (C6, C8, C16 ceramides, and C8-dihydroceramide), to a lesser extent on C2-ceramide and C6-dihydroceramide, but not on other lipids, such as various sphingosines. Binds phosphoinositides.

References

Sugiura M.,et al.J. Biol. Chem. 277:23294-23300(2002).
Van Veldhoven P.P.,et al.Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
Collins J.E.,et al.Genome Biol. 5:R84.1-R84.11(2004).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Dunham I.,et al.Nature 402:489-495(1999).

FeedBack
Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

$ 425.00
Cat# ALS10651
Size:
Quantity:
Availability: 5 days
Bulk Size
Seasonal Special on Bulk Order
Request Quote Here

Ordering Information

United States
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaCentral AmericaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSouth KoreaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamWorldwideOthers
Abgent, Inc.
(888) 735-7227 / (858) 622-0099
(858) 622-0609
USA Headquarters
(888) 735-7227 / (858) 622-0099 or (858) 875-1900

Shipping Information

Domestic orders (in stock items)
Shipped out the same day. Orders placed after 1 PM (PST) will ship out the next business day.
International orders
Contact your local distributors
“Crown Flash”  50 % off on 2,500+ Crown Antibodies. PromoCode:<span class=text-red> FLASH50
Terms & Conditions